- Home
- BWAY vs ZVIA Comparison
BWAY vs ZVIA Comparison
Compare BWAY & ZVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWAY
- ZVIA
- Stock Information
- Founded
- BWAY 2003
- ZVIA 2007
- Country
- BWAY Israel
- ZVIA United States
- Employees
- BWAY N/A
- ZVIA N/A
- Industry
- BWAY Medical/Dental Instruments
- ZVIA Beverages (Production/Distribution)
- Sector
- BWAY Health Care
- ZVIA Consumer Staples
- Exchange
- BWAY Nasdaq
- ZVIA Nasdaq
- Market Cap
- BWAY 280.7M
- ZVIA 227.3M
- IPO Year
- BWAY 2019
- ZVIA 2021
- Fundamental
- Price
- BWAY $15.20
- ZVIA $3.07
- Analyst Decision
- BWAY Strong Buy
- ZVIA Buy
- Analyst Count
- BWAY 2
- ZVIA 4
- Target Price
- BWAY $18.00
- ZVIA $4.61
- AVG Volume (30 Days)
- BWAY 70.6K
- ZVIA 826.6K
- Earning Date
- BWAY 08-13-2025
- ZVIA 08-06-2025
- Dividend Yield
- BWAY N/A
- ZVIA N/A
- EPS Growth
- BWAY 515.14
- ZVIA N/A
- EPS
- BWAY 0.11
- ZVIA N/A
- Revenue
- BWAY $46,084,000.00
- ZVIA $158,371,000.00
- Revenue This Year
- BWAY $341.83
- ZVIA $5.72
- Revenue Next Year
- BWAY $23.42
- ZVIA $6.83
- P/E Ratio
- BWAY $52.60
- ZVIA N/A
- Revenue Growth
- BWAY 26.50
- ZVIA N/A
- 52 Week Low
- BWAY $7.06
- ZVIA $0.90
- 52 Week High
- BWAY $15.61
- ZVIA $4.99
- Technical
- Relative Strength Index (RSI)
- BWAY 78.88
- ZVIA 49.73
- Support Level
- BWAY $14.33
- ZVIA $2.82
- Resistance Level
- BWAY $15.00
- ZVIA $3.22
- Average True Range (ATR)
- BWAY 0.56
- ZVIA 0.21
- MACD
- BWAY 0.33
- ZVIA -0.01
- Stochastic Oscillator
- BWAY 90.26
- ZVIA 32.01
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
About ZVIA Zevia PBC
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.